Ribonucleic acid-based pain medication therapy:  LncRNA NEAT1 increases the expression of PD-L1, attenuates acute and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability, via up-regulation of its target gene, 10/March/2019, 12.45 pm